In a patient with nephrotic syndrome whose urine albumin‑creatinine ratio has risen to 2,484 mg/g (up from 315 mg/g) and urine protein‑creatinine ratio to 3,711 mg/g (up from 134 mg/g), what is the appropriate next step in management?

Urgent Nephrology Referral and Kidney Biopsy Required

This dramatic worsening of proteinuria (urine protein-creatinine ratio from 134 to 3,711 mg/g and albumin-creatinine ratio from 315 to 2,484 mg/g) represents severe nephrotic-range proteinuria requiring urgent nephrology referral within 2 weeks and kidney biopsy to establish the underlying glomerular disease etiology 1, 2.

Immediate Management Priorities

1. Confirm Nephrotic Syndrome Diagnosis

Your patient meets diagnostic criteria for nephrotic syndrome with:

• Proteinuria >3,500 mg/g (you have 3,711 mg/g) 2
• Check serum albumin (likely <30 g/L given this degree of proteinuria)
• Assess for edema
• Check lipid panel (expect hyperlipidemia)

2. Assess Thromboembolism Risk Immediately

Critical decision point: Determine if prophylactic anticoagulation is needed 1:

Check serum albumin now. If albumin <20-25 g/L AND any of the following, start prophylactic anticoagulation:

• Proteinuria >10 g/d (you already have 3.7 g/g ratio, likely approaching this threshold)
• BMI >35 kg/m²
• Heart failure NYHA class III-IV
• Recent orthopedic/abdominal surgery
• Prolonged immobilization

Contraindications to anticoagulation 1:

• Active bleeding diathesis
• Prior GI bleed
• CNS lesions
• Frailty with fall risk
• Patient unable to adhere

If prophylactic anticoagulation indicated 1:

• Use low-molecular-weight heparin (reduce dose if CrCl <30 ml/min) OR
• Unfractionated heparin 5,000 U subcutaneous twice daily
• Warfarin remains the anticoagulant of choice for long-term use (target INR 2-3)
• Monitor INR frequently as warfarin-protein binding fluctuates with changing albumin
• Avoid Factor Xa inhibitors and direct thrombin inhibitors - not adequately studied in nephrotic syndrome and heavily protein-bound 1

3. Initiate Proteinuria-Reducing Therapy

Start ACE inhibitor or ARB immediately 1:

• Titrate to maximally tolerated dose
• Accept serum creatinine increase up to 30% if stable
• Stop only if kidney function continues worsening or refractory hyperkalemia develops

4. Manage Edema

Loop diuretics as first-line 1:

• Furosemide twice daily dosing preferred over once daily
• Increase dose until clinically significant diuresis or maximum effective dose reached
• Switch to bumetanide or torsemide if furosemide fails
• Dietary sodium restriction <2.0 g/day (<90 mmol/day) is essential

For resistant edema, add sequential nephron blockade 1:

• Thiazide diuretic (any high-dose thiazide equally effective) with loop diuretic
• Amiloride (counters hypokalemia, helps metabolic alkalosis)
• Spironolactone (but monitor potassium closely, especially with ACEi/ARB)

Monitor for diuretic complications 1:

• Hypokalemia (loop/thiazide)
• Hyponatremia (thiazide)
• Hyperkalemia (spironolactone + RAS blockade)
• Volume depletion
• Impaired GFR

5. Urgent Nephrology Referral

Refer within 2 weeks 2:

• Kidney biopsy is essential to determine specific glomerular disease (membranous nephropathy, focal segmental glomerulosclerosis, minimal change disease, diabetic nephropathy, etc.)
• Treatment depends entirely on biopsy diagnosis
• Additional testing needed: autoimmune panel, viral hepatitis, serum/urine protein electrophoresis, complement levels

6. Additional Baseline Assessments

• Serum creatinine and eGFR
• Complete metabolic panel (potassium critical before starting ACEi/ARB)
• Lipid panel
• Hepatitis B, C, HIV screening
• Autoimmune serologies (ANA, anti-dsDNA, complement C3/C4)
• Renal ultrasound

Key Pitfalls to Avoid

• Do not delay nephrology referral - this degree of proteinuria worsening demands urgent evaluation 2
• Do not use DOACs (apixaban, rivaroxaban, edoxaban, dabigatran) for anticoagulation in nephrotic syndrome - pharmacokinetics unpredictable with hypoalbuminemia 1
• Do not stop ACEi/ARB for modest creatinine rise (<30% increase) - this is expected and acceptable 1
• Do not forget thromboembolism prophylaxis assessment - recent data confirm excessive thrombin generation and impaired fibrinolysis drive thrombotic risk 3
• Do not assume diabetic nephropathy without biopsy, even in diabetic patients - other glomerular diseases frequently coexist 4

Rationale

The 28-fold increase in protein-creatinine ratio and 8-fold increase in albumin-creatinine ratio represents acute, severe nephrotic syndrome requiring immediate intervention. The KDIGO 2021 guidelines provide the most authoritative framework for management 1. Recent 2025 data confirm that the prothrombotic state is driven by excessive thrombin generation rather than platelet dysfunction, supporting anticoagulation strategies targeting secondary hemostasis 3. Without kidney biopsy, definitive disease-specific treatment cannot be initiated, making urgent nephrology referral the highest priority 2.